Herzliya, Israel

Nucleix


USPTO Granted Patents = 11

% Expired Patents = 9.1


Trademarks = 5

Forward Citations = 14

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Danny Frumkin (10 out of 10 patents)

silverMedal Adam Wasserstrom (10 out of 10 patents)

bronzeMedal Revital Knirsh (5 out of 5 patents)

4 Orna Savin (2 out of 2 patents)

5 Mathias Ehrich (1 out of 38 patents)

6 Dirk Johannes Van Den Boom (1 out of 33 patents)

7 Lawrence Du (1 out of 1 patent)

8 Dan Frumkin (1 patent)

9 Nimrod Axelrad (0 patent)


11 patents:

Nucleix is a biotechnology company dedicated to revolutionizing cancer detection and monitoring through advanced molecular technologies. They develop innovative solutions for early cancer detection, personalized treatment, and monitoring of treatment response, with a focus on liquid biopsy tests. Nucleix's technology utilizes a combination of epigenetics, artificial intelligence, and machine learning to provide accurate and reliable results for improved patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

11 Patents

#35 in Herzliya

#571 in Israel

#51,610 in the World

Herzliya, IL
Herzliya, Israel
Forward Citations = 14

8 inventors:

Please report any incorrect information to [email protected]
Loading…